. Author manuscript; available in PMC: 2007 Apr 24.

Published in final edited form as: Endocrinology. 2003 Sep 18;145(1):401–406. doi: 10.1210/en.2003-0746

TABLE 1.

Microtomographic measurements of BV and trabecular architecture in tibia distal metaphysis in control and rosiglitazone-fed mice

Treatment	BV/TV (%)	TbTh (μm)	TbN (mm⁻¹)	TbSp (mm)	ConnD (mm⁻³)	SMI	DA
Control	15.4 ± 1.7	57.6 ± 1.4	4.20 ± 0.22	0.23 ± 0.05	55.78 ± 16.98	2.08 ± 0.28	2.05 ± 0.10
Rosiglitazone	11.7 ± 1.6^a	51.5 ± 3.2^a	3.73 ± 0.29^a	0.27 ± 0.02^a	42.21 ± 5.18	2.07 ± 0.36	2.14 ± 0.18
P (rosiglitazone vs. control)	0.008	0.008	0.02	0.02	NS	NS	NS

Data are given as mean ± SD; n = 5 animals per group.

NS, not significant (P > 0.05);

P < 0.05.